Laxitextine B - Compound Card

Laxitextine B

Select a section from the left sidebar

Laxitextine B

Structure
Zoomed Structure
  • Family: Fungi - Hericiaceae
  • Kingdom: Fungi
  • Class: Terpenoid
    • Subclass: Cyathane Diterpenoid
Canonical Smiles CC(C1=C2[C@H]3CC[C@H]4[C@@H]5[C@@H]([C@]3(C)CC[C@]2(CC1)C)O[C@H]1[C@]5(O)[C@]2(O[C@@H]4O[C@]2(CO1)O)O)C
InChI InChI=1S/C25H36O7/c1-12(2)13-7-8-21(3)9-10-22(4)15(16(13)21)6-5-14-17-18(22)30-20-24(17,27)25(28)23(26,11-29-20)31-19(14)32-25/h12,14-15,17-20,26-28H,5-11H2,1-4H3/t14-,15+,17+,18-,19-,20-,21+,22+,23-,24-,25-/m0/s1
InChIKey FQOAVARCJFYMTA-BGMCZZGGSA-N
Formula C25H36O7
HBA 7
HBD 3
MW 448.56
Rotatable Bonds 1
TPSA 97.61
LogP 2.43
Number Rings 7
Number Aromatic Rings 0
Heavy Atom Count 32
Formal Charge 0
Fraction CSP3 0.92
Exact Mass 448.25
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Laxitextum incrustatum Hericiaceae Fungi 1812024

Showing of synonyms

  • Mudalungu CM, Richter C, et al. (2016). Laxitextines A and B, Cyathane Xylosides from the Tropical Fungus Laxitextum incrustatum.. Journal of Natural Products,2016,22,79(4),894-898. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: C1CCC(C=12)CCC3C4C5C6C7C(COC6O4)OC(O7)C5CCC23

Level: 0

Mol. Weight: 448.56 g/mol

Antibacteria
Antiproliferative

Absorption

Caco-2 (logPapp)
-5.05
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.85
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-1.76

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.85
Plasma Protein Binding
78.06
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
7.2
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-1.61
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-1.4
Liver Injury II
Safe
hERG Blockers
Toxic
Daphnia Maga
7.18
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-139.98
Rat (Acute)
3.12
Rat (Chronic Oral)
2.41
Fathead Minnow
3.58
Respiratory Disease
Toxic
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Toxic
SR-p53
Safe

General Properties

Boiling Point
392.87
Hydration Free Energy
-3.15
Log(D) at pH=7.4
3.41
Log(P)
3.52
Log S
-4.22
Log(Vapor Pressure)
-10.66
Melting Point
206.93
pKa Acid
6.09
pKa Basic
5.0

No predicted protein targets found for this compound.

Download SDF